Skip to main content
. 2018 Mar 26;14:601–606. doi: 10.2147/TCRM.S159211

Table 1.

Patient’s characteristics

Ondansetron group (n=102) Ramosetron group (n=104) P-value
Age (years) 42.6±10.9 43.7±11.9 0.50
Women 97 (95.1) 96 (92.3) 0.41
Body mass index (kg/m2) 23.4±4.0 23.2±3.1 0.58
ASA physical status 0.44
 1 83 (81.4) 79 (76.0)
 2 20 (19.6) 25 (24.0)
History of PONV or motion sickness 38 (37.3) 42 (40.4) 0.65
Nonsmoking 99 (97.1) 100 (96.2) 1.00
Simplified risk score 0.78
 2 10 (10.2) 11 (10.6)
 3 57 (55.9) 59 (56.7)
 4 35 (34.3) 34 (32.7)
Duration of anesthesia (min) 123.9±47.5 121.4±66.2 0.75
Duration of surgery (min) 94.1±45.2 92.2±64.6 0.81
Duration of PACU stay (min) 67.2±24.4 70.6±25.6 0.32
Use of fentanyl-based IV PCA 70 (68.6) 59 (56.7) 0.08
Type of surgical procedure 0.35
 Cholecystectomy 34 (33.3) 43 (41.3)
 Hysterectomy 21 (20.6) 18 (17.3)
 Ovarian cystectomy 19 (18.6) 20 (19.2)
 Myomectomy 19 (18.6) 13 (12.5)
 Salpingo-oophorectomy 6 (5.9) 8 (7.7)
 Other gynecologic surgery 3 (2.9) 2 (1.9)

Note: Values are presented as mean ± standard deviation or number (%) of patients.

Abbreviations: ASA, American Society of Anesthesiologists; PONV, postoperative nausea and vomiting; PACU, postanesthesia care unit; IV PCA, intravenous patient-controlled analgesia.